Team:NYU Abu Dhabi/ResultsBio

Bio Results

Biology Results

Successful ligation, transformation, inoculation, and plasmid extractions of the genes for pcaA (Tuberculosis), HBcAg (Hepatitis B), IS481 (Whooping Cough), and ypo2088 (Plague)
Compared sensitivity limit of detection of RPA and PCR
Compared sensitivity limit of detection of RPA and PCR + CRISPR
Performed successful PCR and RPA on samples directly from LB broth for IS481 and HBcAg

Preparation and Verification of pure DNA samples
Sensitivity Test with Polymerase Chain Reaction (PCR) and Recombinase Polymerase Amplification (RPA)
CRISPR Verification Using Fluorescence Quencher (FQ) Reporter
Test Using Bacteria from LB broth
Detection Using CRISPR-Cas12a

Preparation and Verification of pure DNA samples

In the results below, the following gene codes each is an indicator of a particular disease:

Gene	Disease	gBlock Size (bp)
pcaA	Tuberculosis	455
HbcAg	Hepatitis B	537
IS481	Whooping Cough	509
ypo2088	Plague	585

PCR-amplified gblocks of the respective genes were ligated to pJET vectors. E. coli were transformed with the ligated vectors using heat-shock. Three colonies from each bacteria plate were picked separately for inoculation and subsequent plasmid extraction and purification through minipreps. For DNA quantification and purity measurements, NanoDrop was used and one miniprep for each gene with high purity and concentration was selected to conduct the experiments that follow thereafter.

NanoDrop Results of chosen Miniprep:

Gene/Miniprep	Concentration (ng/μl)	260/280	260/230
IS481 sample 2	129.7	1.89	2.24
HBcAg sample 2	90.0	1.92	2.28
ypo2088 sample 3	77.5	1.93	2.32
pcaA sample 3	111.9	1.93	2.26

Table 1: Summary of Nanodrop results for the genes selected for further experimentation.

Moreover, all miniprepped samples were PCR amplified to ensure the incorporation of the correct target gene into the plasmid DNA.

Figure 1: PCR amplification of miniprepped samples of pcaA, HBcAg, and IS481 for quality control. (‘MP’ stands for Miniprep, IS481* refers to IS481 minipreps derived from ligation and transformation from a previous IS481 miniprep sample )

Figure 2: PCR amplification of genes with pJET to verify ligation (ypo2088). Left to right: 500bp Ladder, negative control, ypo2088 Miniprep 1, ypo2088 Miniprep 2, ypo2088 Miniprep 3

The electrophoresis results show bands that match the gBlock lengths for the following miniprep samples:

pcaA miniprep 1
hbcAg minipreps 1, 2, and 3
IS481 minipreps 1 and 2
Ypo2088 minipreps 1, 2, and 3

Hence, we concluded that the clear bands present at around 500 bp for these miniprep samples, obtained through PCR primers specific for each gene, confirmed that they are properly incorporated into the plasmid DNA. Therefore, these samples were used in further experimentation. Those with no corresponding amplicon lengths were subsequently discarded.

Sensitivity Test with Polymerase Chain Reaction (PCR) and Recombinase Polymerase Amplification (RPA)

The sensitivity of RPA with our genes was tested by conducting RPA reactions on serial dilutions of 60 ng/μl, 25 ng/μl, 10 ng/μl, 5 ng/μl, 1 ng/μl, 0.1 ng/μl, 0.01 ng/μl, and 0.001 ng/μl. The same serial dilutions were also used in the PCR reactions as a standard for comparison with RPA.

	PCR	RPA
pcaA (Tuberculosis)
HBcAg (Hepatitis B)
IS481 (Whooping cough)
ypo2088 (Plague)

Table 2: Comparison of PCR and RPA sensitivity on all genes. For each gene, PCR and RPA was performed on the following serial dilutions: 60 ng/μl, 25 ng/μl, 10 ng/μl, 5 ng/μl, 1 ng/μl, 0.1 ng/μl, 0.01 ng/μl, 0.001 ng/μl as well as negative control

The length of the RPA amplicons are summarized below:

pcaA: 158 bp
HBcAg:
IS481:
Ypo2088: 98 bp

Genes	PCR sensitivity limit (ng/μl)	RPA sensitivity limit (ng/μl)
pcaA	5	1
HbcAg	1	0.001
IS481	0.1	0.001
ypo2088	1	0.01

Table 3: Sensitivity limit comparison between PCR and RPA amplifications of serial-diluted plasmid DNA

In all cases, RPA exhibited higher sensitivity compared to PCR. This is important in the functionality of Volatect, as it gives the device stronger capability to pick up on genetic markers of communicative diseases over traditional amplification techniques (PCR) currently in use. The high sensitivity of RPA allows Volatect to amplify DNA and detect pathogens in saliva even when the concentration of the bacteria/viruses is low, hence boosting concentration of target genes for CRISPR activation.

CRISPR Verification Using Fluorescence Quencher (FQ) Reporter

During the second phase of our project, we optimized the SYBR green concentration from the 2018 iGEM NYUAD team to utilize its property as a fluorescent nucleic acid stain to verify RPA reactions ran on microfluidic chip prototypes. In order to cater to the volume requirements of the engineering team’s microfluidic chip with the wet laboratory experiments, we greatly modified the RPA protocol from the original one by TwistDX to one that utilizes the volumes that can fit within the tubes of the chip. This new protocol utilizes 15 μl of RPA TwistAmp Basic Mastermix and 4 μl of DNA.

I0.56µL of 1000X SYBR Green was added to an IS481 (Whooping Cough) RPA sample following the new protocol in accordance with the engineering team’s requirements.

Agarose Gel Electrophoresis Result	Fluorescence Test Using SYBR Green

Table 4: Verification of RPA amplification using 1000x SYBR green. Fluorescence was observed only in the samples where the DNA was amplified (as indicated by the presence of bands in the gel). No fluorescence was indicated in the negative control where DNA was not amplified.

As shown by the gel results and the results under UV light, the fluorescence was apparent only in the tubes where the RPA segment was amplified, and no fluorescence appeared when no bands appeared (in the negative control sample). This experiment verified the viability of SYBR green can be used to determine if the DNA segment was amplified by RPA.

Next, SYBR green was further diluted to a final concentration of 1.25X and tested on the serial dilutions of ypo2088 to assess if it can be used to detect DNA amplification at different concentrations (serial dilutions) of DNA.

Figure 5: Using 25X SYBR green to detect DNA amplification using RPA for all serial dilutions (ypo2088).

As per the figure, SYBR green only showed fluorescence in all the serial dilutions samples containing DNA (with various concentrations). Since these samples fluoresced using only 1μl of SYBR green from a 25x stock, this can reduce the amount needed for amplification detection and reduce the cost in the device.

In future studies, we aim to expand the detection range of Volatect to include RNA viruses, which are the cause of several travel illnesses and epidemics (ex: Ebola and HIV). In order to do this, we plan to use a variant of our CRISPR reagent, CRISPR-Cas13, which can detect RNA accurately. The technique we will use, called SHERLOCK, is based on the protocol titled “Nucleic acid detection with CRISPR-Cas13a/C2c2,” which provides “rapid DNA or RNA detection with attomolar sensitivity and single-base mismatch specificity.” The protocol illustrates the proof-of-concept whereby SHERLOCK is able to detect specific strains of Zika and Dengue virus. Like DETECTR (the protocol utilized by Volatect), SHERLOCK also relies on the use of a cleavage reporter to indicate the presence of the target nucleic acid. In addition, our collection method should include adding a buffer able to lyse viruses.

Click here for the SHERLOCK protocol:
https://science.sciencemag.org/content/356/6336/438/tab-pdf

If the experiments were repeated, some steps need to be considered by the experimenters:

The concentrations of SYBR green and FQ quencher must be adjusted depending on the total volume of the sample (whether PCR or RPA) to determine the one that results in the least background fluorescence.
The type of guide RNAs used for CRISPR detection must be consistent with the Cas enzyme used. For instance, if using the LbCas12a enzyme, Lb guides must be used for the guide RNAs to bind to the target DNA and release fluorescence.